Aprogen Medicines Inc. (007460.KS) KSC

703.00

-6(-0.85%)

Updated at December 05 12:46PM

Currency In KRW

Valuation

Market Cap200.5B
Enterprise Value277.04B
P/E Ratio-3.68
PEG Ratio0.15
Price/Sales Ratio1.59
Price/Book Ratio1.43
Enterprise/Revenue2.34
Enterprise/EBITDA-3.92

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.44
Operating Margin-0.77

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.39

Income Statement

Revenue150.11B
Revenue/Share433.71
Gross Profit34.9B
EBITDA-73.38B
Net Income-58.08B
Diluted EPS-224.79

Balance Sheet

Total Cash147.91B
Total Cash/Share503.78
Total Debt229.27B
Total Debt/Equity1.61
Current Ratio1.02
Book Value Per Share1,699.38

Price History

52-Week Change-22
52-Week High952
52-Week Low556
Moving Average 50 Days654.04
Moving Average 200 Days685.87

Statistics

Average Volume5.15M
Shares Outstanding291.07M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:3
Last Split DateJanuary 19, 2023